About
Single Cell Isolation
Areas of Focus
Categories
Non-PharmaceuticalBoston & New England
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
4
As Collaborator
3
Total Enrollment
932
By Phase
PHASE2: 1PHASE1: 4PHASE1/PHASE2: 1PHASE3: 1
By Status
RECRUITING: 4ACTIVE_NOT_RECRUITING: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07216443Lead Sponsor
Reduced Intensity or Nonmyeloablative Conditioning With Orca-T for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
PHASE2Recruiting
80 participants
Started: Oct 7, 2025 · Completed: Dec 31, 2028
NCT06900192Collaborator
A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis
PHASE1Not yet recruiting
10 participants
Started: Mar 31, 2025 · Completed: Aug 31, 2029
NCT05322850Collaborator
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
PHASE1/PHASE2Recruiting
40 participants
Started: Aug 16, 2022 · Completed: Sep 30, 2027
NCT05316701Lead Sponsor
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
PHASE3Active, not recruiting
187 participants
Started: Jun 21, 2022 · Completed: Jul 31, 2026
NCT05088356Collaborator
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
PHASE1Recruiting
60 participants
Started: Sep 7, 2021 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Bradford, CT, United States
Map
Loading map...